People: Zealand Pharma A/S (ZEAL.OQ)

ZEAL.OQ on NASDAQ Stock Exchange Global Select Market

1:30am IST
Change (% chg)

$-0.08 (-0.52%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Blom, Mats 

Mr. Mats Peter Blom has been Senior Vice President, Chief Financial Officer and Member of the Executive Management at Zealand Pharma A/S since January 3, 2011. Before that, he has been Vice President and CFO of the Company since March 1, 2010. He served as CFO at Swedish Orphan International a leading European orphan drug company. He has extensive managerial experience and has held CFO positions at Active Biotech and Anoto both publicly listed on Nasdaq Stockholm. Previously, Mats worked for several years as a management consultant at Gemini Consulting and at Ernst & Young’s Transaction Services division. He holds a BA in Business Administration and Economics from the University of Lund followed by an MBA from IESE University of Navarra, Barcelona. Mats is Chairman of the Board for Medical Need AB.

Basic Compensation

Total Annual Compensation, DKK 4,598,000
Restricted Stock Award, DKK --
Long-Term Incentive Plans, DKK --
All Other, DKK --
Fiscal Year Total, DKK 4,598,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --